These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
644 related articles for article (PubMed ID: 26319344)
41. [Does acetylsalicylic acid and vitamin K antagonists are risk factors of macular degeneration related with age?]. Jończyk-Skórka K; Śliwczyńska-Rodziewicz D; Jarmak A; Kowalski J Pol Merkur Lekarski; 2015 Mar; 38(225):144-9. PubMed ID: 25815614 [TBL] [Abstract][Full Text] [Related]
42. Age related macular degeneration - new developments in treatment. Smith TC; Lee L Aust Fam Physician; 2007 May; 36(5):359-61. PubMed ID: 17492074 [TBL] [Abstract][Full Text] [Related]
43. Development of gene therapy for treatment of age-related macular degeneration. Askou AL Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666 [TBL] [Abstract][Full Text] [Related]
44. Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes. Song SJ; Youm DJ; Chang Y; Yu HG Ophthalmic Epidemiol; 2009; 16(5):304-10. PubMed ID: 19874110 [TBL] [Abstract][Full Text] [Related]
46. The quest to conquer age-related macular degeneration. Bryan RG Med Health R I; 2008 Feb; 91(2):51-3, 56. PubMed ID: 18372860 [TBL] [Abstract][Full Text] [Related]
47. Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study. Boekhoorn SS; Isaacs A; Uitterlinden AG; van Duijn CM; Hofman A; de Jong PT; Vingerling JR Ophthalmology; 2008 Nov; 115(11):1899-903. PubMed ID: 18708255 [TBL] [Abstract][Full Text] [Related]
48. Age-related macular degeneration in Onitsha, Nigeria. Nwosu SN Niger J Clin Pract; 2011; 14(3):327-31. PubMed ID: 22037079 [TBL] [Abstract][Full Text] [Related]
49. Overview of progress in the epidemiology of age-related macular degeneration. Klein R Ophthalmic Epidemiol; 2007; 14(4):184-7. PubMed ID: 17896295 [TBL] [Abstract][Full Text] [Related]
50. Prevalence of age-related macular degeneration in an elderly urban chinese population in China: the Jiangning Eye Study. Ye H; Zhang Q; Liu X; Cai X; Yu W; Yu S; Wang T; Lu W; Li X; Jin H; Hu Y; Kang X; Zhao P Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6374-80. PubMed ID: 25190650 [TBL] [Abstract][Full Text] [Related]
51. Diabetes, cardiovascular morbidity, and risk of age-related macular degeneration in a primary care population. Vassilev ZP; Ruigómez A; Soriano-Gabarró M; García Rodríguez LA Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1585-92. PubMed ID: 25670489 [TBL] [Abstract][Full Text] [Related]
52. Interventions for Age-Related Macular Degeneration: Are Practice Guidelines Based on Systematic Reviews? Lindsley K; Li T; Ssemanda E; Virgili G; Dickersin K Ophthalmology; 2016 Apr; 123(4):884-97. PubMed ID: 26804762 [TBL] [Abstract][Full Text] [Related]
53. Prevalence of Age-Related Macular Degeneration in Slovakia and Associated Risk Factors: A Mobile Clinic-Based Cross-Sectional Epidemiological Survey. Krasnik V; Stefanickova J; Popov I; Valaskova J; Saxena S; Kruzliak P Semin Ophthalmol; 2018; 33(4):506-511. PubMed ID: 28524715 [TBL] [Abstract][Full Text] [Related]
54. Age-related macular degeneration, anti-vascular endothelial growth factor agents, and short-term mortality: a postmarketing medication safety and surveillance study. French DD; Margo CE Retina; 2011 Jun; 31(6):1036-42. PubMed ID: 21836410 [TBL] [Abstract][Full Text] [Related]
55. Age-related macular degeneration. Can we stem this worldwide public health crisis? Starr CE; Guyer DR; Yannuzzi LA Postgrad Med; 1998 May; 103(5):153-6, 161-4. PubMed ID: 9590992 [TBL] [Abstract][Full Text] [Related]